Back to Search Start Over

Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis.

Authors :
Leclercq, Mathilde
Sené, Thomas
Chapelon-Abric, Catherine
Desbois, Anne Claire
Domont, Fanny
Maillart, Elisabeth
Shor, Natalia
Vignal-Clermont, Catherine
Guéguen, Antoine
Bodaghi, Bahram
Cacoub, Patrice
Touitou, Valerie
Saadoun, David
Source :
Ocular Immunology & Inflammation. 2022, Vol. 30 Issue 4, p821-828. 8p.
Publication Year :
2022

Abstract

Neuro-ophthalmologic manifestations are uncommon in sarcoidosis. We aim to assess the prognostic factors and outcome of neuro-ophthalmic sarcoidosis. We conducted a multicenter retrospective study on patients with neuro-ophthalmic sarcoidosis. Response to therapy was based on visual acuity, visual field, and orbital MRI exam. Factors associated with remission and relapse were analyzed. Thirty-five patients [median (IQR) age of 37 years (26.5–53), 63% of women] were included. The diagnosis of sarcoidosis was concomitant of neuro-ophthalmologic symptoms in 63% of cases. Optic neuritis was the most common manifestation. All patients received corticosteroids and 34% had immunosuppressants. At 6 months, 61% improved, 30% were stable, and 9% worsened. Twenty percent of patients had severe visual deficiency at the end of follow-up. Nonresponders patients had significantly worse visual acuity at baseline (p = 0.01). Relapses were less frequent in patients with retro-bulbar optic neuropathy (p = 0.03). Prognosis of neuro-ophthalmic sarcoidosis is poor. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09273948
Volume :
30
Issue :
4
Database :
Academic Search Index
Journal :
Ocular Immunology & Inflammation
Publication Type :
Academic Journal
Accession number :
158808654
Full Text :
https://doi.org/10.1080/09273948.2020.1834585